BD Alaris Infusion Set FDA Alert Puts Kit Supply Chains Under the Spotlight
The BD Alaris infusion set FDA alert reaches hospitals through Cardinal Health Presource kits. What procurement and supply teams need to know.
The BD Alaris infusion set FDA alert reaches hospitals through Cardinal Health Presource kits. What procurement and supply teams need to know.
The global healthcare AI regulatory network shares real-time warnings on harmful AI incidents. What Poland joining means for patient safety and oversight.
The Roche Q3 2026 results beat forecasts, while giredestrant, fenebrutinib and a reported Hansoh deal shape how Roche plans to replace expiring products.
The US Ebola travel declaration is the latest step after May and July entry bars. A timeline of the rules, what changes on 3 November and what is unknown.
The Shamonda virus human case in France: official statements, the ECDC comment, the animal context and the open questions investigators are working on.
Natco generic risdiplam: what parents, officials and an expert say about approval, labelling and price of the low-cost SMA drug in Kerala.
The Mosquirix malaria vaccine price cut is a conditional UNICEF and Gavi deal: €5.50 a dose, about US$50 million in savings, milestones to meet.
The Moderna Merck melanoma vaccine met its Phase 3 goals. What regulators will weigh next, and what the companies have not yet said.
The Microsoft AI diagnostic tool beat physicians on hard cases and now heads for ER triage testing. What the evidence shows and does not.